UKFHD 61st Academic Meeting
UKFHD 61st Academic Meeting
Wednesday 20th May 2026
ETC Venues, 11 Portland Street, Manchester, M1 3HU
The UK Forum on Haemoglobin Disorders meetings receive financial support with sponsorship arrangements from their industry partners.
Dear Colleague
Just in case you missed the details previously, the full programme is now available for the UKFHD 61st Academic Meeting which is being held in Manchester on Wednesday 20th May 2026.
Please note that attendance for this meeting is in person only with no live stream option available.
To view the programme please click here – Programme
Further details can be found on the meeting website – UKFHD 61st Academic Meeting
Registration
Registration fees for healthcare professionals working in the NHS:
| UKFHD Members*
Attend in Person: £0.00 |
Non-Members
Attend in Person: £15.00 |
*Members must be fully paid to date to qualify
To book your place please click here – Register
Please see below for another meeting which may also be of interest:
National Meeting – Medical Haematology Evidence Update
Post ISTH & ASH Headlines 2026
Tuesday 22nd September 2026
Examination Schools, 75-81 High Street, Oxford OX1 4BG
This national Medical Haematology Evidence Update meeting will include sessions covering relevant topics in bleeding disorders, red cell disorders, immune haematology and thrombosis and DOACs.
Programme
To view the programme please click here – Programme
Registration
Online Registration is now available – Register
All sponsors have provided sponsorship towards these independent programmes. Sponsors have had no input into the content of the programmes or the choice of speakers (unless declared on the programme) and have provided sponsorship monies used towards the meeting costs. Sponsors will have the opportunity to exhibit with a company stand during the meetings.
Emma trained at St Barts and the Royal London School of Medicine, University of London and qualified in 2001 and is currently working as a Haematology Consultant between UCLH and the Whittington Hospital. She was Clinical Lecturer in Sickle Cell Disease at King’s College Hospital from 2009 to 2013 and during that time was awarded her PhD based on research into markers of severity and predictors of organ dysfunction in sickle cell disease. In 2013 she was awarded the Early Stage Investigator prize from the British Society of Haematology. She is the Haemoglobinopathy Coordinating Centre lead for North Central and West London, East Anglia and the South West and Central England.
John James OBE has 33 years of experience within the NHS including 4 CEO roles. He was Chair of the West London Cancer network (2002-2005) and Chair of the North West London Diabetes Network (2003-2004). 
Dr Subarna Chakravorty is a Paediatric Haematologist with a special interest in non-malignant haematology and stem cell transplant for haemoglobinopathy and non-malignant diseases. She joined King’s College Hospital as consultant in July 2015. Prior to that, Subarna led the Paediatric Haemoglobinopathy service at Imperial College Healthcare NHS Trust and the Imperial Paediatric Red Cell Disorders Network for 5 years, where she was also involved in the bone marrow transplant programme for paediatric haemoglobinopathy. Since 2021, Subarna has been involved in the adult sickle cell bone marrow transplant service at King’s College Hospital.
Dr Rachel Kesse-Adu is a consultant haematologist who qualified in medicine from Imperial College School of Medicine in 2002 and completed her specialist training in haematology at Kings College Hospital in London in 2012.